4Go AS,Chertow GM,Fan DJ,et al.Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization[J].N Engl J Med,2004,351:1296-1305.
5Gunnell J,Yeun JY,Depner TA,et al.Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients[J].Am J Kidney Dis,1999,33:63-72.
6Kaysen GA.Malnutrition and the acute-phase reaction in dialysis patients-how to measure and how to distinguish[J]?Nephrol Dial Transplant,2000,15:1521-1524.
7Dencer D,Besik F,Ogu ZU.Genes of major histocomplatihility compex class Ⅱ influence chronic hepatitis treatments with interferon in hemodialysis patients[J].Int J Artif Organs,2001,24(4):212-214.
8Vanholder R,Ringoir S,Dhondt A,et al.Phagocytosis in uremic and hemodialysis patients:a prospective and sectional study[J].Kidney Int,1991,39:320-327.
9王海燕主编.肾脏病学[M].第2版.北京:人民卫生出版社,1997:708-719
10Mak W, Greene EL. Cardiovascular risk factors in chronic renal failure and hemodialysis population[J]. AM Kidney Dis, 1992,515:505.
